You just read:

FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Multiple Invasive Fungal and Mold Infections

News provided by

Amplyx Pharmaceuticals

Nov 16, 2016, 08:06 ET